{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:42:45Z","timestamp":1771306965166,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dental Sciences"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jds.2022.10.030","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T17:40:18Z","timestamp":1667929218000},"page":"1156-1163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5580-6680","authenticated-orcid":false,"given":"Masanori","family":"Nashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Hashitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shibatsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Furudoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6437-8614","authenticated-orcid":false,"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-296X","authenticated-orcid":false,"given":"Toshihiko","family":"Takenobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jds.2022.10.030_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic (1)","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jds.2022.10.030_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00774-021-01223-4","article-title":"Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis","volume":"39","author":"Aoki","year":"2021","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.jds.2022.10.030_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J Bone Miner Metabol"},{"key":"10.1016\/j.jds.2022.10.030_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdsr.2018.09.002","article-title":"Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"55","author":"Kishimoto","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.jds.2022.10.030_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5794\/jjoms.68.161","article-title":"The number of patients with bisphosphonate-related osteonecrosis of the jaws still increases significantly in Japan \u2013 based on the data from annual survey of the oral diseases by JAOMS","volume":"68","author":"Kishimoto","year":"2022","journal-title":"Jpn J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib8","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.joms.2011.03.051","article-title":"Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan","volume":"69","author":"Urade","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.joms.2018.04.009","article-title":"National survey on bisphosphonate-related osteonecrosis of the jaws in Japan","volume":"76","author":"Shibahara","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.13852","article-title":"Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss","volume":"85","author":"Dion\u00edsio","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jds.2022.10.030_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jds.2022.10.030_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5794\/jjoms.53.594","article-title":"A survey of bisphosphonate-related osteomyelitis\/osteonecrosis of the jaws","volume":"53","author":"Shimahara","year":"2007","journal-title":"Jpn J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib14","first-page":"5","article-title":"Multicenter survey of medication related osteonecrosis of the jaw in Hyogo Prefectural Hospital Dentistry","volume":"22","author":"Shudo","year":"2015","journal-title":"Jpn Oral Infect dis"},{"key":"10.1016\/j.jds.2022.10.030_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","article-title":"Prevalence, incidence rate, and risk factors of medication-related osteonecrosis of the jaw in patients with osteoporosis and cancer: a nationwide population-based study in Japan","volume":"80","author":"Ishimaru","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac Surg Clin"},{"key":"10.1016\/j.jds.2022.10.030_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bjoms.2014.11.008","article-title":"United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis","volume":"53","author":"Rogers","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2022.10.030_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.jds.2022.10.030_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jds.2022.10.030_bib20","first-page":"4763","article-title":"Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases","volume":"29","author":"Ikesue","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jds.2022.10.030_bib21","article-title":"Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours","volume":"26","author":"Zheng","year":"2017","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jds.2022.10.030_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jds.2022.10.030_bib23","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jds.2022.10.030_bib24","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00198-018-4621-7","article-title":"Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study","volume":"29","author":"Shudo","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jds.2022.10.030_bib25","first-page":"7241","article-title":"Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study","volume":"30","author":"Soutome","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jds.2022.10.030_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00280-021-04262-w","article-title":"Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases","volume":"87","author":"Ikesue","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jds.2022.10.030_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jbmr.4472","article-title":"Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis","volume":"37","author":"Everts-Graber","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jds.2022.10.030_bib28","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1038\/s41598-022-11615-9","article-title":"A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients","volume":"12","author":"Jung","year":"2022","journal-title":"Sci Rep"}],"container-title":["Journal of Dental Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790222002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790222002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:18:00Z","timestamp":1761851880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1991790222002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1991790222002823"],"URL":"https:\/\/doi.org\/10.1016\/j.jds.2022.10.030","relation":{},"ISSN":["1991-7902"],"issn-type":[{"value":"1991-7902","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Dental Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jds.2022.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}